Evidence map›Paper›PMID 35078525›Full record

ArticleEuropean journal of medical research2022

CT-based radiomic nomogram for predicting the severity of patients with COVID-19.

Hengfeng Shi, Zhihua Xu, Guohua Cheng, Hongli Ji, Linyang He, Juan Zhu, Hanjin Hu, Zongyu Xie, Weiqun Ao, Jian Wang

Abstract read
In one paragraph

Article in European journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. CT-based radiomics nomogram for distinguishingTranslational pediatrics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hengfeng Shi *Department of Radiology, Anqing Municipal Hospital, Anqing, Anhui, China.
Zhihua Xu *Department of Radiology, Tongde Hospital of Zhejiang Province, No. 234, Gucui Road, Hangzhou, Zhejiang, China.
Guohua ChengJianpei Technology, Hangzhou, Zhejiang, China.
Hongli JiJianpei Technology, Hangzhou, Zhejiang, China.
Linyang HeJianpei Technology, Hangzhou, Zhejiang, China.
Juan ZhuDepartment of Radiology, Anqing Municipal Hospital, Anqing, Anhui, China.
Hanjin HuDepartment of Radiology, Anqing Municipal Hospital, Anqing, Anhui, China.
Zongyu XieDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Weiqun Ao *Department of Radiology, Tongde Hospital of Zhejiang Province, No. 234, Gucui Road, Hangzhou, Zhejiang, China. 78123858@qq.com.
Jian Wang *Department of Radiology, Tongde Hospital of Zhejiang Province, No. 234, Gucui Road, Hangzhou, Zhejiang, China. 119202405@qq.com.ORCID http://orcid.org/0000-0002-8222-9639

Funding

Coronavirus disease 2019 (COVID-19) emergency plan project of Anqing 2020Z1003
6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) is a pandemic now, and the severity of COVID-19 determines the management, treatment, and even prognosis. We aim to develop and validate a radiomics nomogram for identifying patients with severe COVID-19.

methodsThere were 156 and 104 patients with COVID-19 enrolled in primary and validation cohorts, respectively. Radiomics features were extracted from chest CT images. Least absolute shrinkage and selection operator (LASSO) method was used for feature selection and radiomics signature building. Multivariable logistic regression analysis was used to develop a predictive model, and the radiomics signature, abnormal WBC counts, and comorbidity were incorporated and presented as a radiomics nomogram. The performance of the nomogram was assessed through its calibration, discrimination, and clinical usefulness.

resultsThe radiomics signature consisting of four selected features was significantly associated with clinical condition of patients with COVID-19 in the primary and validation cohorts (P < 0.001). The radiomics nomogram including radiomics signature, comorbidity and abnormal WBC counts showed good discrimination of severe COVID-19, with an AUC of 0.972, and good calibration in the primary cohort. Application of the nomogram in the validation cohort still gave good discrimination with an AUC of 0.978 and good calibration. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful to identify the severe COVID-19.

conclusionWe present an easy-to-use radiomics nomogram to identify the patients with severe COVID-19 for better guiding a prompt management and treatment.

Indexed as

NomogramsAdultCohort StudiesCOVID-19FemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedCOVID-19RadiomicsSARS-CoV-2X-ray computed tomography

Identifiers

PMID35078525
PMCPMC8787184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.